Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Epidemiology. 2015 May;26(3):374–380. doi: 10.1097/EDE.0000000000000284

TABLE 1.

Characteristics of 49 Patients with 328 Confirmed Atrial Fibrillation Episodes

Number of Patientsa Number of Episodes ≥ 30 Secondsa
Male 33 (67%) 253 (77%)
Race/ethnicity
 White 47 (96%) 310 (95%)
 Black 2 (4%) 18 (6%)
History of atrial fibrillation 24 (49%) 204 (62%)
Previous myocardial infarction 28 (62%) 205 (66%)
Previous stroke 5 (10%) 24 (7%)
History of congestive heart failure 31 (63%) 275 (84%)
History of revascularization
 Coronary artery bypass grafting 15 (31%) 145 (44%)
 Percutaneous coronary intervention 13 (27%) 69 (21%)
Comorbidities
 Pulmonary disease 13 (27%) 66 (20%)
 Diabetes 13 (27%) 112 (34%)
 Hypertension 27 (56%) 197 (62%)
Indications for implant
 Primary 31 (63%) 199 (61%)
 Secondary (cardiac arrest or sustained ventricular tachycardia) 7 (14%) 29 (9%)
 Syncope apparently arrhythmic 11 (23%) 100 (31%)
Structural heart disease
 Ischemic 30 (61%) 225 (69%)
 Non-ischemic 10 (20%) 35 (11%)
 Other 9 (18%) 68 (21%)
History of sleep apnea 7 (16%) 92 (30%)
Obese (body mass index ≥ 30) 15 (31%) 137 (42%)
Medications
 Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker 41 (87%) 311 (96%)
 Beta blocker 43 (92%) 313 (97%)
 Anti-arrhythmic agents 10 (21%) 117 (36%)
 Platelet aggregation inhibitors 31 (66%) 153 (47%)
 Statin 38 (81%) 264 (82%)
Air conditioning use
 Central 15 (33%) 155 (53%)
 Window 28 (61%) 121 (41%)
 None 3 (7%) 19 (6%)
Use of a humidifier 8 (17%) 85 (29%)

Values are n (%).

a

Percents may not add up to 100 due to rounding. Missing values (patients, events): previous myocardial infarction, n = (4, 16); previous stroke, n = (1, 1); pulmonary disease, n = (1, 1); history of sleep apnea, n = (4, 24); medications, n = (2, 4); air conditioning use, n = (3, 33); use of a humidifier, n = (3, 33).